Clinical Trials Logo
  1. Home
  2. Cerebral Vasospasm
  3. NCT02712788

Milrinone in Addition to Hyperdynamic Therapy in the Treatment of Vasospasm Following Aneurysmal Subarachnoid Hemorrhage

Cerebral Vasospasm Clinical Trial

Official title:
Milrinone in Addition to Hyperdynamic Therapy in the Treatment of Vasospasm Following Aneurysmal Subarachnoid Hemorrhage

Clinical Trial Summary

The purpose of this study is to evaluate the usefulness of adding Milrinone to the current standard treatment for cerebral vasospasm.

Clinical Trial Description

The goal of this study is to assess the efficacy of milrinone as an agent to treat cerebral vasospasm by adding it to standard therapy. This will take the form of a randomized, controlled trial in which patients will receive either standard hyperdynamic therapy or hyperdynamic therapy + milrinone. The hypothesis of this study is that good outcomes will be 25% more common in the experimental (milrinone) group than the control (standard therapy) group. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02712788
Study type Interventional
Source Indiana University
Contact
Status Terminated
Phase Phase 2
Start date April 18, 2016
Completion date May 3, 2018
View Details
See also
  Status Clinical Trial Phase
Completed NCT02275949 - Acupuncture for Cerebral Vasospasm After Subarachnoid Hemorrhage N/A
Completed NCT02389634 - Identification of Novel Molecular Markers for Vasospasm
Completed NCT00962546 - Computed Tomographic (CT) Perfusion and CT Angiography as Screening Tools for Vasospasm Following Subarachnoid Hemorrhage N/A
Not yet recruiting NCT04512859 - Stellate Ganglion Block in Preventing Cerebral Vasospasm Secondary to Subarachnoid Hemorrhage N/A
Completed NCT01024972 - Safety Study of Dantrolene in Subarachnoid Hemorrhage Phase 1/Phase 2
Completed NCT00692744 - Quality of Life in Elderly After Aneurysmal Subarachnoid Hemorrhage (SAH) N/A
Completed NCT04208477 - "The Effect of Stellate Ganglion Block in Severe Brain Injury" N/A
Recruiting NCT06303349 - Predictive Model for the Occurrence of Cerebral Vasospasm Complicating Subarachnoid Haemorrhage by Combined Analysis of the Kinetics of a Panel of Biomarkers. N/A
Recruiting NCT02129413 - Safety Study of Carotid Body Neurostimulation to Treat Cerebral Vasospasm N/A
Terminated NCT00582868 - Use of Brain Oxygen Tension Level and Cleaved-tau Protein to Detect Vasospasm After SAH N/A
Terminated NCT00487461 - Use of Simvastatin for the Prevention of Vasospasm in Aneurysmal Subarachnoid Hemorrhage N/A
Withdrawn NCT01878136 - Effect of Intraventricular tPA Following Aneurysmal Subarachnoid Hemorrhage Phase 1/Phase 2
Withdrawn NCT01091870 - Sildenafil for Prevention of Cerebral Vasospasm Phase 2
Completed NCT03214705 - Role of CT Perfusion in Predicting Poor Outcome After Subarachnoid Hemorrhage
Recruiting NCT05150002 - Cervical Spinal Cord Stimulation in Patients With Cerebral Vasospasm After Subarachnoid Haemorrhage: VasoStim Study N/A
Completed NCT01187420 - Bilateral Bispectral Index (BIS) Study N/A
Enrolling by invitation NCT05230134 - Cervical Sympathetic Block in Patients With Cerebral Vasospasm N/A
Withdrawn NCT02426827 - Cervical Spinal Cord Stimulation in Cerebral Vasospasm N/A
Withdrawn NCT00871065 - Safety Study of Sildenafil in Treatment of Cerebral Aneurysm Vasospasm Phase 2
Recruiting NCT04691271 - Stellate Ganglion Block and Cerebral Vasospasm N/A